We Make Life Count
Over 25 years of cutting-edge research in life-saving vaccines and infectious diseases
The Vaccines and Infectious Diseases Analytics (“VIDA”) Research Unit of the University of the Witwatersrand (“Wits”), is an African-led research unit that combines clinical, microbiological and epidemiological expertise to deliver scientific breakthroughs in the field of vaccines and infectious diseases. We strive to make a meaningful difference to the communities around us, as well as at a global level through pioneering work led by accomplished teams.
Research Focus Areas
Wits VIDA’s current focus areas include next-generation vaccines against rotavirus and TB, as well as development of novel vaccines targeted at pregnant women to protect their young infants against the leading causes of sepsis and pneumonia.
-
Epidemiology & vaccines against Group B streptococcus disease
Identifying protein antigens common to most GBS invasive isolates with potential to be developed into vaccines.
-
Influenza Epidemiology & Influenza Vaccines
This research aims to identify protein antigens common to most GBS invasive isolates with potential to be developed into vaccine candidates.
-
Risk Factors, incl. impact of the Vaginal Microbiome, on Fetal Outcomes
Impact of the vaginal microbiome on risk of poor obstetric outcome, and risk for early-onset sepsis in the neonate.
-
Epidemiology & Prevention of Pneumococcal Disease
Wits VIDA was pivotal in the introduction of the PCV into the South African National EPI.
-
Child Health & Mortality Program on Surveillance
Saving children’s lives by collecting, analysing, and sharing data about the causes of child mortality in regions where it is highest.
-
Epidemiology & Prevention of Pneumonia Morbidity & Sequelae in Children
Pneumonia still remains a leading cause of hospitalization and death among children in SA and globally.
-
Prevention of Diarrheal Disease
Following research by the unit, SA was the first African country to introduce the rotavirus vaccine into a public immunization program.
-
Immunity in HIV-Exposed & HIV-Uninfected Children
Study on the immune mediators which might contribute to HIV-exposed uninfected infants (HEUs) having a higher incidence of severe infections.
-
Covid Epidemiology in South Africa
Study on the immune mediators which might contribute to HIV-exposed uninfected infants (HEUs) having a higher incidence of severe infections.
News, Events & Resources
Wits VIDA is proudly celebrating the 30th year of transforming global public health through innovation, collaboration and research. We invite you to be part of this experience with us as we reach a significant milestone in our journey to produce impactful change that affect the lives of thousands.